19 results
Thumbnail

D1.250 - Beyond the Label: A Multidisciplinary Effort to De-label Penicillin Allergy

Thumbnail

D1.251 - Documentation of drug allergy in the Electronic Health Record (EHR) at a Tertiary paediatric allergy service in the UK

Thumbnail

D1.252 - A model based economic evaluation to assess impact of Penicillin Allergy in COPD patients

Thumbnail

D1.253 - Comparison of Immune-Related Adverse Events in Patients Treated with Atezolizumab and Durvalumab: A Critical Concern for Clinical Management

Thumbnail

D1.254 - Assessing the Accuracy of Penicillin Allergy Labels in Paediatric Care: Focusing on Educational Gaps in Both Families and Healthcare Workers

Thumbnail

D1.255 - Validation of the English Version of the Drug Hypersensitivity Quality of Life Questionnaire (DrHy-Q): A Cross-Cultural Adaptation and Reliability Study

Thumbnail

D1.256 - Development of multiple drug hypersensitivity after DRESS syndrome induced by piperacillin/tazobactam

Thumbnail

D1.257 - Extensive allergological workup in the management of immediate adverse drug reactions to chemotherapy- a single centre experience

Thumbnail

D1.258 - Comparison of the Negative Predictive Values of One-Day and Five-Day Drug Provocation Tests in Late-Mild and Cutaneous Beta-Lactam Allergies in Children

Thumbnail

D1.260 - Hypersensitivity to Iodinated Contrast Media: Diagnostic Evaluation and Re-exposure Outcomes

Thumbnail

D1.248 - Perioperative hypersensitivity reaction (POH) with tranexamic acid: study of 2 cases

Thumbnail

D1.249 - Improving inpatient antimicrobial stewardship through single dose oral amoxicillin challenge among penicillin allergic veterans

Thumbnail

D3.265 - Biphasic anaphylaxis secondary to polyethylene glycol in a pediatric patient: a case report

Thumbnail

D3.269 - Drug-Induced Anaphylaxis in Children: A Comparative Analysis of Inpatient vs. Outpatient Settings

Thumbnail

D3.272 - Safety and Efficacy of Vancomycin and Other Antimicrobial Drug Desensitization in Pediatric Patients

Thumbnail

D3.273 - Assessing Anaphylaxis in COVID-19 vaccines: Application of amended Brighton Collaboration Criteria

Thumbnail

D3.274 - Succesful Omalizumab Desensitization in Two Children with Severe Allergic Asthma and Cronic Spontaneous Urticaria

Thumbnail

D3.275 - Anaphylaxis caused by polyhexanide

Thumbnail

D3.276 - Acalabrutinib as premedication in platinum agents desensitization protocols: a case series supporting its role in enhancing tolerance with a repeatible efficacity